CDK6 and breast cancer: We identified several proteins in our BC-PDM resistance/sensitivity panel to be predictive for PAB response that have been linked to PAB resistance/sensitivity in previous studies, such as CDK6, Cyclin E1, FGFR, Cyclin D1 and ERα [134].